High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.

about

High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.

Item

http://www.wikidata.org/entity/Q47201561

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

High molecular weight fibrobla ...... atrial fibrillation patients.

@en

High molecular weight fibrobla ...... atrial fibrillation patients.

@nl

type

Item

label

High molecular weight fibrobla ...... atrial fibrillation patients.

@en

High molecular weight fibrobla ...... atrial fibrillation patients.

@nl

prefLabel

High molecular weight fibrobla ...... atrial fibrillation patients.

@en

High molecular weight fibrobla ...... atrial fibrillation patients.

@nl

P1476

High molecular weight fibrobla ...... atrial fibrillation patients.

@en

P2093

Gao-Shu Zheng

http://www.w3.org/2001/XMLSchema#string

Hao Zhou

http://www.w3.org/2001/XMLSchema#string

Ling-Yue Sun

http://www.w3.org/2001/XMLSchema#string

Ling-Zhi Chen

http://www.w3.org/2001/XMLSchema#string

Wei-Jian Huang

http://www.w3.org/2001/XMLSchema#string

Xiang Qu

http://www.w3.org/2001/XMLSchema#string

Xing-Xing Chen

http://www.w3.org/2001/XMLSchema#string

Zhi-Ting Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

Biological activities of fibroblast growth factor-2 in the adult myocardium.

P2888

s00380-017-1019-y

P304

1506-1512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00380-017-1019-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28689282

http://www.w3.org/2001/XMLSchema#string